These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18400472)

  • 21. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?
    Becker HE; Nieman DH; Wiltink S; Dingemans PM; van de Fliert JR; Velthorst E; de Haan L; van Amelsvoort TA; Linszen DH
    Psychol Med; 2010 Oct; 40(10):1599-606. PubMed ID: 20132582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
    Chen CK; Lin SK; Chen YC; Huang MC; Chen TT; Ree SC; Wang LJ
    Drug Alcohol Depend; 2015 Mar; 148():158-64. PubMed ID: 25601645
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis.
    Brewer WJ; Francey SM; Wood SJ; Jackson HJ; Pantelis C; Phillips LJ; Yung AR; Anderson VA; McGorry PD
    Am J Psychiatry; 2005 Jan; 162(1):71-8. PubMed ID: 15625204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive deficits and levels of IQ in adolescent onset schizophrenia and other psychotic disorders.
    Fagerlund B; Pagsberg AK; Hemmingsen RP
    Schizophr Res; 2006 Jul; 85(1-3):30-9. PubMed ID: 16626945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis.
    Lo Cascio N; Saba R; Hauser M; Vernal DL; Al-Jadiri A; Borenstein Y; Sheridan EM; Kishimoto T; Armando M; Vicari S; Fiori Nastro P; Girardi P; Gebhardt E; Kane JM; Auther A; Carrión RE; Cornblatt BA; Schimmelmann BG; Schultze-Lutter F; Correll CU
    Eur Child Adolesc Psychiatry; 2016 Oct; 25(10):1091-102. PubMed ID: 26921232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neurocognitive effectiveness of haloperidol, risperidone, and olanzapine in first-episode psychosis: a randomized, controlled 1-year follow-up comparison.
    Crespo-Facorro B; Rodríguez-Sánchez JM; Pérez-Iglesias R; Mata I; Ayesa R; Ramirez-Bonilla M; Martínez-Garcia O; Vázquez-Barquero JL
    J Clin Psychiatry; 2009 Apr; 70(5):717-29. PubMed ID: 19389335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Associations between substance use, neuropsychological functioning and treatment response in psychosis.
    deVille M; Baker A; Lewin TJ; Bucci S; Loughland C
    Psychiatry Res; 2011 Apr; 186(2-3):190-6. PubMed ID: 20843558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IQ as a predictor of functional outcome in schizophrenia: a longitudinal, four-year study of first-episode psychosis.
    Leeson VC; Barnes TR; Hutton SB; Ron MA; Joyce EM
    Schizophr Res; 2009 Jan; 107(1):55-60. PubMed ID: 18793828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cognitive dimensions in first-episode schizophrenia spectrum disorders.
    González-Blanch C; Crespo-Facorro B; Alvarez-Jiménez M; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; Vázquez-Barquero JL
    J Psychiatr Res; 2007 Dec; 41(11):968-77. PubMed ID: 17049561
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurocognitive performance and functional disability in the psychosis prodrome.
    Niendam TA; Bearden CE; Johnson JK; McKinley M; Loewy R; O'Brien M; Nuechterlein KH; Green MF; Cannon TD
    Schizophr Res; 2006 May; 84(1):100-11. PubMed ID: 16563699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive deficits in nonaffective functional psychoses: a study in the Democratic Republic of Congo.
    Ngoma M; Vansteelandt K; Delespaul P; Krabbendam L; Miezi SM; Peuskens J
    Psychiatry Res; 2010 Dec; 180(2-3):86-92. PubMed ID: 20494461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive improvement in first-episode schizophrenia and healthy controls: A 6-year multi-assessment follow-up study.
    Fu S; Czajkowski N; Torgalsbøen AK
    Psychiatry Res; 2018 Sep; 267():319-326. PubMed ID: 29957548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex differences in cognitive functioning in at-risk mental state for psychosis, first episode psychosis and healthy control subjects.
    Ittig S; Studerus E; Papmeyer M; Uttinger M; Koranyi S; Ramyead A; Riecher-Rössler A
    Eur Psychiatry; 2015 Feb; 30(2):242-50. PubMed ID: 25555341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Premorbid adjustment and clinical correlates of cognitive impairment in first-episode psychosis. The PEPsCog Study.
    Cuesta MJ; Sánchez-Torres AM; Cabrera B; Bioque M; Merchán-Naranjo J; Corripio I; González-Pinto A; Lobo A; Bombín I; de la Serna E; Sanjuan J; Parellada M; Saiz-Ruiz J; Bernardo M;
    Schizophr Res; 2015 May; 164(1-3):65-73. PubMed ID: 25819935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First episode psychosis patients show impaired cognitive function--a study of a South Asian population in the UK.
    Saleem MM; Harte MK; Marshall KM; Scally A; Brewin A; Neill JC
    J Psychopharmacol; 2013 Apr; 27(4):366-73. PubMed ID: 23427189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome.
    Addington J; Saeedi H; Addington D
    Schizophr Res; 2005 Oct; 78(1):35-43. PubMed ID: 15978781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis.
    Fraguas D; Merchán-Naranjo J; del Rey-Mejías Á; Castro-Fornieles J; González-Pinto A; Rapado-Castro M; Pina-Camacho L; Díaz-Caneja CM; Graell M; Otero S; Baeza I; Moreno C; Martínez-Cengotitabengoa M; Rodríguez-Toscano E; Arango C; Parellada M
    Schizophr Res; 2014 Sep; 158(1-3):126-33. PubMed ID: 25034759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigating cognitive deficits and symptomatology across pre-morbid adjustment patterns in first-episode psychosis.
    Béchard-Evans L; Iyer S; Lepage M; Joober R; Malla A
    Psychol Med; 2010 May; 40(5):749-59. PubMed ID: 19732482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
    Lam M; Lee J; Rapisarda A; See YM; Yang Z; Lee SA; Abdul-Rashid NA; Kraus M; Subramaniam M; Chong SA; Keefe RSE
    JAMA Psychiatry; 2018 Sep; 75(9):929-939. PubMed ID: 30046827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.